Press the button and be introduced to a new random company!

Introduce me >

Social media

facebook   Follow us on Twitter




Read in Swedish

Vitrolife AB (publ): Vitrolife postpones the Annual General Meeting

08:30 / 2 April 2020 Vitrolife Press release

Due to the great uncertainty caused by the extensive dissemination of covid-19, Vitrolife's Board of Directors has decided to postpone the Annual General Meeting to a later date.

The Annual General Meeting was originally scheduled to be held on April 28, 2020 in Gothenburg. Vitrolife will return with a notice to the AGM no later than four weeks before the new date. The meeting will be held in accordance with current legislation.

Gothenburg, Sweden
April 2, 2020


Vitrolife is an international medical device Group. Vitrolife develops, produces and markets medical devices for assisted reproduction.

Vitrolife has approximately 400 employees and the company's products are sold in about 110 markets. The company is headquartered in Gothenburg, Sweden, and there are also offices in Australia, Belgium, China, Denmark, France, Germany, Italy, Japan, United Kingdom and USA. The Vitrolife share is listed on NASDAQ Stockholm.

Vitrolife AB (publ), Box 9080, SE-400 92 Göteborg, Sweden. Corporate identity number 556354-3452. Tel: 46 31 721 80 00. Fax: 46 31 721 80 99. E-mail:

Show as PDF

Show original from Cision


This information was distributed by Cision